Creating Intelligent and Technological E-Cig Products: Jinjia Corporation's Vision

Business by 2FIRSTS.ai

Dec.14.2023

Creating Intelligent and Technological E-Cig Products: Jinjia Corporation's Vision

Investors ask if Jinjia Corp's e-cigarette has artificial intelligence, company aims to improve product performance to create intelligent, technological e-cigarettes.

On December 14th, an investor questioned on the investor interaction platform: Does your company's e-cigarette incorporate artificial intelligence?

Jinyu Corporation (002191.SZ) announced that the company will continuously enhance the performance of its e-cigarette products to meet the demands of customers and the market, aiming to create smart and technologically advanced e-cigarette products.

References:

[1] 请问贵司的电子烟搭载了人工智能吗

Also Read:

[1] Development and Market Expansion Strategy of Jinjia Group's Tobacco Business

[2] Tobacco Licenses Obtained by Jingjia Holdings' Subsidiaries

[3] Jinjia Group: Business Declining while Diversifying into New Materials

#Asia #Open system e-cigarettes #China #Technology.#Products #Product #jinjia

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Insights | From Limited-Edition Frenzy to Interactive Lead-Gen: The 2025 Halloween Shift in Vape Marketing

For Halloween 2025, leading vape brands such as HQD and ELFBAR are running overseas social-media engagement campaigns—covering points programs and UGC giveaways with age/region restrictions. Unlike 2024’s wave of themed devices, no brand-new Halloween limited editions have appeared on major U.S. channels this year; only RAZ has restocked last year’s version.

Oct.31 by 2FIRSTS.ai

Cambodia Enforces Full Ban on E-Cigarettes and Shisha to Protect Youth

Cambodian Prime Minister Hun Manet signs order to strengthen enforcement of e-cigarette and shisha bans, citing health risks and youth usage.

Oct.23 by 2FIRSTS.ai

PMI Launches VEEV E-Cigarette in South Africa, Expanding Access to Smoke-Free Alternatives

Philip Morris International's South Africa branch launches e-cigarette product Veev, making South Africa one of 20 countries with PMI's smoke-free products.

Oct.13 by 2FIRSTS.ai

ceshi1111

Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st